Like other common vaccines designed to prevent or reduce the effects of viral infection, a new cancer vaccine is showing exciting efficacy in protecting against a range of cancers. Initial tests at the University of Massachusetts Amherst are among the first successfully combining nanoparticles and an adjuvant to block tumor growth. Of Mice and Antigens
The hype around artificial intelligence has reached a fever pitch, with its acolytes celebrating rapid advancements in computer power and use in novel applications. AI’s role in healthcare, particularly in cancer research, presents one of the most exciting possibilities. Most of AI’s success has been in accelerating the process or reducing the time needed to
Experts have had no shortage of potential causes, but no clear answers to explain the meteoric rise in colon cancer diagnoses in young adults. Over the past two decades, adults under 55 have seen colon cancer rates double. Gut bacteria may be a contributing factor. Researchers have considerable evidence that colibactin could be a part
A small study has shown positive results in a new mRNA vaccine. The findings, published in Nature, show promise, though the study's limited size and long clinical research timeline mean it will be years before it’s a viable option for patients. About the Vaccine The mRNA vaccine is personalized for individual use and trains T
Despite the robust marketing and billions in annual sales, the evidence supporting the claimed health benefits of multivitamins is scant. One of the largest studies ever completed on the subject reports little to no impact on cardiovascular disease or cancer. The question of whether multivitamins are truly beneficial remains a fascinating and open one. Multivitamin
Today’s healthcare system creates reams of data that require careful collection, analysis, and implementation to improve cancer care outcomes. Cancer informatics, or CI, is a large and widening field that marks the confluence of healthcare, computer science, and analytics. Effective cancer informatics programs may ultimately improve care, accelerate research, and save thousands of lives by
Intratumoral immunotherapy has put the immune system center stage in the fight against metastasized cancer. While its use has primarily been limited to melanoma, intratumoral therapy has also had some success in slowing the spread of other types of cancer. This innovative procedure has tremendous upside, though more research and robust clinical trials are still
The record-breaking 18-month dash to develop a COVID-19 vaccine could accelerate cancer vaccines by the end of the decade. Similar vaccines could treat autoimmune, cardiovascular and other forms of diseases along the same timeline. So claims Moderna’s chief medical officer, Dr. Paul Burton. The US pharmaceutical company is building on its pandemic-era work to develop
Cancer claims the lives of more than 10 million people per year. Still, deaths caused by cancer are on the decline, decreasing by 33% since 1991. While underreported during the pandemic, cancer remains of the leading causes of cancer worldwide, claiming more lives than COVID-19. Younger People Are Getting Cancer While deaths have declined, a
The Less Cancer campaign- program of Next Generation Choices Foundation is pleased to announce the first Move Detroit for Less Cancer to be held December 1,2012 at the Bayview Yacht Club,located at 100 Clairpointe Street Detroit, MI 48215. For nearly a decade, Less Cancer has been at the helm introducing prevention into the cancer
